期刊文献+

米非司酮在妇产科中的应用 被引量:7

Application of mifepristone in obstetrics and gynecology
下载PDF
导出
摘要 米非司酮是一种合成类固醇,具有抗孕酮、抗糖皮质激素和轻度抗雄激素特性,其对子宫内膜孕激素受体的亲和力比孕酮高5倍,具有终止早孕、促宫颈成熟等作用。随着对米非司酮作用机制及临床应用的深入研究,其应用范围不断扩大,在终止中期妊娠、晚期妊娠引产、稽留流产和死胎的引产、避孕、宫腔操作前预处理以及对子宫肌瘤、子宫内膜异位症、功能性子宫出血、异位妊娠的治疗等方面均有应用,并取得了较好的临床效果。该文就其在临床的具体效用及应用经验作以综述。 Mifepristone is a synthetic steroid. It exerts effects of antiprogesterone, antiglucocorticoid and weak effect of antiandrogen. It can terminate early pregnancy and promote cervical ripening because its affinity to endometrial progesterone receptor is five times higher than progesterone. With deepening in study on its mechanism and application in clinic, the application range of mifepristone has been extended continuously, for example, it has been also applied in termination of midtrimester of pregnancy, induction of labor in late pregnancy, missed abortion and stillbirth, contraception,pretreatment before operation in uterine cavity, and treatment of hysteromyomas, endometriosis, dysfunctional uterine bleeding(DUB), ectopic pregnancy and so on.
作者 何燕南 杨静
出处 《中国妇幼健康研究》 2010年第2期256-258,共3页 Chinese Journal of Woman and Child Health Research
关键词 米非司酮 妇产科 临床应用 临床进展 mifepristone obstetrics and gynecology clinical application progress in clinical study
  • 相关文献

参考文献25

  • 1Beal M W. Update on medication abortion[ J]. J Midwifery Womens Health,2007,52( 1 ) :23-30. 被引量:1
  • 2Vayrynen W, Heikinheimo O, Nuutila M. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death [ J]. Acta Obstet Gynecol Scand, 2007,86 ( 6 ) : 701-705. 被引量:1
  • 3Kapp N, Borgatta L, Stubblefield P, et al. Mifepristone in secondtrimester medical abortion : A randomized controlled trial [ J ]. Obstet Gynecol,2007,110 (6) : 1304-1310. 被引量:1
  • 4Middleton T, Schaff E, Fielding S L, et al. Randomized trial of mifepristone and buccal or vaginal misopmstol for abortion through 56 days of last menstrual period [ J ]. Contraception, 2005,72 : 328- 332. 被引量:1
  • 5Jerbi M S, Hidar W. Mife pristone a la dose de 100mg dans les avortements m dieamenteux[ J ]. Gynecol Obstet Biol Reprod, 2005, 34 (cahier 1 ) :257-261. 被引量:1
  • 6Von Hertzen H, Piaggio G, Wojdyla D. Two mifepristone doses and two intervals of prostol administration for termination of early pregnancy :A randomized factorial controlled equivalence trial [ J ]. BJOG,2009,116(3) :381-389. 被引量:1
  • 7Tang O S, Chan C C, Kan A S, et al. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12 -20 weeks gestation[ J]. Hum Reprod ,2005,20( 11 ) :3062-3066. 被引量:1
  • 8Hamoda H, Ashok P W, Flett G M, et al. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13 - 20 weeks gestation[ J]. Hum Reprod,2005,20( 8 ) :2348-2354. 被引量:1
  • 9Bhattacharjee N, Saha S P, Ghoshroy S C, et al. A randomized comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks [ J]. Aust N Z J Obstet Gynaecol,2008,8 (2) :165-171. 被引量:1
  • 10Tang O S, Gemzell D K, Ho P C. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects [ J ]. hat J Gynaecol Obstet,2007,99 ( Suppl 2 ) : S160-S167. 被引量:1

同被引文献31

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部